The challenge of improving outcomes in locally advanced cervical cancer

被引：1
作者：
Mileshkin, Linda R. [1 ,2 ]
机构：
[1] Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic 3000, Australia
[2] Univ Melbourne, Melbourne, Vic 3000, Australia
来源：
LANCET ONCOLOGY | 2023年 / 24卷 / 12期
关键词：
D O I：
10.1016/S1470-2045(23)00532-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1289 / 1291
页数：3
相关论文
共 10 条
  • [1] Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study
    Chung, Hyun Cheol
    Ros, Willeke
    Delord, Jean-Pierre
    Perets, Ruth
    Italiano, Antoine
    Shapira-Frommer, Ronnie
    Manzuk, Lyudmila
    Piha-Paul, Sarina A.
    Xu, Lei
    Zeigenfuss, Susan
    Pruitt, Scott K.
    Leary, Alexandra
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (17) : 1470 - +
  • [2] Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer
    Colombo, N.
    Dubot, C.
    Lorusso, D.
    Caceres, M., V
    Hasegawa, K.
    Shapira-Frommer, R.
    Tewari, K. S.
    Salman, P.
    Usta, E. Hoyos
    Yanez, E.
    Gumus, M.
    de Mendoza, M. Olivera Hurtado
    Samouelian, V
    Castonguay, V
    Arkhipov, A.
    Toker, S.
    Li, K.
    Keefe, S. M.
    Monk, B. J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (20) : 1856 - 1867
  • [3] Combining Radiotherapy and Immunotherapy in Metastatic Breast Cancer: Current Status and Future Directions
    David, Steven
    Tan, Jennifer
    Siva, Shankar
    Karroum, Lama
    Savas, Peter
    Loi, Sherene
    [J]. BIOMEDICINES, 2022, 10 (04)
  • [4] Phase II study of atezolizumab in combination with bevacizumab in patients with advanced cervical cancer
    Friedman, Claire F.
    Charen, Alexandra Snyder
    Zhou, Qin
    Carducci, Michael A.
    De Meritens, Alexandre Buckley
    Corr, Bradley R.
    Fu, Siqing
    Hollmann, Travis J.
    Iasonos, Alexia
    Konner, Jason A.
    Konstantinopoulos, Panagiotis A.
    Modesitt, Susan C.
    Sharon, Elad
    Aghajanian, Carol
    Zamarin, Dmitriy
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [5] PD-1/PD-L1 inhibitors for advanced or metastatic cervical cancer: From bench to bed
    Huang, Weijia
    Liu, Jiewei
    Xu, Kai
    Chen, Huilin
    Bian, Ce
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [6] Merck, 2023, Merck announces phase 3 KEYNOTE -A18 trial met primary endpoint of progression -free survival (PFS) in patients with newly diagnosed high -risk locally advanced cervical cancer
  • [7] Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial
    Monk, Bradley J.
    Toita, Takafumi
    Wu, Xiaohua
    Limon, Juan C. Vazquez
    Tarnawski, Rafal
    Mandai, Masaki
    Shapira-Frommer, Ronnie
    Mahantshetty, Umesh
    Estevez-Diz, Maria del Pilar
    Zhou, Qi
    Limaye, Sewanti
    Godinez, Francisco J. Ramirez
    Kussler, Christina Oppermann
    Varga, Szilvia
    Valdiviezo, Natalia
    Aoki, Daisuke
    Leiva, Manuel
    Lee, Jung-Yun
    Sulay, Raymond
    Kreynina, Yulia
    Cheng, Wen-Fang
    Rey, Felipe
    Rong, Yi
    Ke, Guihao
    Wildsmith, Sophie
    Lloyd, Andrew
    Dry, Hannah
    Nunes, Ana Tablante
    Mayadev, Jyoti
    [J]. LANCET ONCOLOGY, 2023, 24 (12) : 1334 - 1348
  • [8] Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
    Sung, Hyuna
    Ferlay, Jacques
    Siegel, Rebecca L.
    Laversanne, Mathieu
    Soerjomataram, Isabelle
    Jemal, Ahmedin
    Bray, Freddie
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2021, 71 (03) : 209 - 249
  • [9] Survival with Cemiplimab in Recurrent Cervical Cancer
    Tewari, K. S.
    Monk, B. J.
    Vergote, I
    Miller, A.
    de Melo, A. C.
    Kim, H-S
    Kim, Y. M.
    Lisyanskaya, A.
    Samouelian, V
    Lorusso, D.
    Damian, F.
    Chang, C-L
    Gotovkin, E. A.
    Takahashi, S.
    Ramone, D.
    Pikiel, J.
    Mackowiak-Matejczyk, B.
    Alia, E. M. Guerra
    Colombo, N.
    Makarova, Y.
    Rischin, D.
    Lheureux, S.
    Hasegawa, K.
    Fujiwara, K.
    Li, J.
    Jamil, S.
    Jankovic, V
    Chen, C-, I
    Seebach, F.
    Weinreich, D. M.
    Yancopoulos, G. D.
    Lowy, I
    Mathias, M.
    Fury, M. G.
    Oaknin, A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (06) : 544 - 555
  • [10] Reducing Uncertainties About the Effects of Chemoradiotherapy for Cervical Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data From 18 Randomized Trials
    Vale, Claire
    Tierney, Jayne F.
    Stewart, Lesley A.
    Brady, Mark
    Dinshaw, Ketayun
    Jakobsen, Anders
    Parmar, Mahesh K. B.
    Thomas, Gillian
    Trimble, Ted
    Alberts, David S.
    Chen, Hongwei
    Cikaric, Slobodan
    Eifel, Patricia J.
    Garipagaoglu, Melahat
    Keys, Henry
    Kantardzic, Nermina
    Lal, Punita
    Lanciano, Rachelle
    Leborgne, Felix
    Lorvidhaya, Vicharn
    Onishi, Hiroshi
    Pearcey, Robert G.
    Pras, Elizabeth
    Roberts, Kenneth
    Rose, Peter G.
    Thomas, Gillian
    Whitney, Charles W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (35) : 5802 - 5812
1